900,0
+0,00%
2026-10-16
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +19.6% | -358.6% | 2 / 3 | -98.9% | +85.18 pp | -5228.15 pp | +40.3% | -0.42 | — | 0,2 | −98,9% | −9,3 | +19,6% | — | -0.43 | — |
| Pts | 0 | 0 | 8 | 0 | 12 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 900,0 (close price on 2026-10-16)EPS (TTM): −12.364,6
Financial charts
1.Revenue & growth
VND bn0,18Q2/26
1.Revenue & growth
VND bn0,18Q2/26
2.Profit & growth
VND bn-8,96Q2/26
3.Profit mix (Penman)
VND bn-186Q2/26
4.Margins & cost structure
%8.2%Q2/26
5.Returns & cash cycle
% · days42.7%Q2/26
6.Earnings quality & cash
VND bn9,68Q2/26
7.Asset structure
VND bn3,58Q2/26
8.Funding & debt health
VND bn · times3,58Q2/26
9.Revenue backlog
VND bn0,49Q2/26
10.Valuation
times · %-0,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-585Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26